Inter-laboratory variability of A549 epithelial cells grown under submerged and air-liquid interface conditions

Toxicol In Vitro. 2021 Sep:75:105178. doi: 10.1016/j.tiv.2021.105178. Epub 2021 Apr 24.

Abstract

In vitro cell models offer a unique opportunity for conducting toxicology research, and the human lung adenocarcinoma cell line A549 is commonly used for toxicology testing strategies. It is essential to determine whether the response of these cells grown in different laboratories is consistent. In this study, A549 cells were grown under both submerged and air-liquid interface (ALI) conditions following an identical cell seeding protocol in two independent laboratories. The cells were switched to the ALI after four days of submerged growth, and their behaviour was compared to submerged conditions. The membrane integrity, cell viability, morphology, and (pro-)inflammatory response upon positive control stimuli were assessed at days 3, 5, and 7 under submerged conditions and at days 5, 7, and 10 at the ALI. Due to the high variability of the results between the two laboratories, the experiment was subsequently repeated using identical reagents at one specific time point and condition (day 5 at the ALI). Despite some variability, the results were more comparable, proving that the original protocol necessitated improvements. In conclusion, the use of detailed protocols and consumables from the same providers, special training of personnel for cell handling, and endpoint analysis are critical to obtain reproducible results across independent laboratories.

Keywords: Alveolar epithelial cells; In vitro model; Inter-laboratory assessment; Lung model; Standard operating procedure.

MeSH terms

  • A549 Cells
  • Cell Culture Techniques*
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Epithelial Cells* / drug effects
  • Humans
  • Interleukin-6 / metabolism
  • Interleukin-8 / metabolism
  • Laboratories
  • Lipopolysaccharides / pharmacology
  • Reproducibility of Results
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • CXCL8 protein, human
  • IL6 protein, human
  • Interleukin-6
  • Interleukin-8
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha